Details for New Drug Application (NDA): 080857
✉ Email this page to a colleague
NDA 080857 describes DIPHENYLAN SODIUM, which is a drug marketed by Chartwell Molecular and is included in one NDA. Additional details are available on the DIPHENYLAN SODIUM profile page.
The generic ingredient in DIPHENYLAN SODIUM is phenytoin sodium. There are twenty-one drug master file entries for this compound. Twenty-four suppliers are listed for this compound. Additional details are available on the phenytoin sodium profile page.
The generic ingredient in DIPHENYLAN SODIUM is phenytoin sodium. There are twenty-one drug master file entries for this compound. Twenty-four suppliers are listed for this compound. Additional details are available on the phenytoin sodium profile page.
Summary for 080857
| Tradename: | DIPHENYLAN SODIUM |
| Applicant: | Chartwell Molecular |
| Ingredient: | phenytoin sodium |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE;ORAL | Strength | 30MG PROMPT | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE;ORAL | Strength | 100MG PROMPT | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
